Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/25/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. John L. Kolman

Wrong Dr. John L. Kolman?

Executive Director

Phone: (301) ***-****  
Email: j***@***.com
BioReliance Corporation
14920 Broschart Road
Rockville , Maryland 20850
United States

Company Description: BioReliance Corporation is a contract service organization that provides services for biologics and other biomedical products to biotechnology and pharmaceutical...   more

Employment History


  • PhD , Molecular Biophysics and Biochemistry
    Yale University
  • undergraduate degree cum laude , Honors Biology and Chemistry
    University of Illinois
  • Master's degree , Molecular Biophysics and Biochemistry
    Yale University
21 Total References
Web References
:: BioReliance ::, 13 Feb 2007 [cached]
BioReliance Corporation announced today that John L. Kolman, PhD, has been named Senior Director, Research and Development.
Speaker/Bios « 2011 PDA Annual Meeting, 25 April 2011 [cached]
John Kolman
John Kolman
Dr. Kolman joined BioReliance in April of 2008 as head of the newly formed Global Research and Development as well as the Department of Genomics. Prior to that, he was a Principal Scientist in the Corporate Research Laboratory of Invitrogen Corp. There, he built collaborations with academic thought leaders and led cross-department teams in the application of cutting edge technologies to novel, high-impact areas.
John received his Ph.D from Yale University for the study of molecular events underpinning Epstein-Barr virus lytic activation. He then continued with a post-doctoral appointment at the Salk Institute, eventually rising to Staff Scientist. His career has been motivated by the study of difficult biological questions using new molecular approaches.
John L. Kolman, PhD, Joins BioReliance Corp. As Senior Director, Research and Development Baltimore, 22 April 2008 [cached]
John L. Kolman, PhD, Joins BioReliance Corp.As Senior Director, Research and Development
Description:ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance Corporation announced today that John Ludwig Kolman, PhD, has been named Senior Director, Research and Development.He reports to Vice President and Chief Scientific Officer (CSO) David Onions, PhD.
BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide.
Dr. Kolman was previously with Invitrogen Corporation (NASDAQ: IVGN) as the Principal Scientist on the HLA Single Antigen Initiative and Lung Cancer Biomarker Programs.Before that he conducted research at the Salk Institute, La Jolla, California, focusing on DNA replication initiation.He is co-inventor of a method to detect multiple antigens (patent pending) and widely published.
After earning an undergraduate degree cum laude with majors in Honors Biology and Chemistry from University of Illinois, Dr. Kolman earned a Master's degree and PhD in Molecular Biophysics and Biochemistry from Yale University.
"I am delighted that John has joined BioReliance as Senior Director of R&D," said Dr. Onions."He has a tremendous record of achievement in research both in the academic setting and in industry.His appointment, plus our investment in new R&D laboratories, signal a new era in this company's history and reflects our commitment to the development innovative products and services for our customers."
"BioReliance has become a highly dynamic organization, entering a high growth phase based on accelerated and strategic R&D," said Dr. Kolman.
Speakers / World PGx by Hanson Wade, 10 Oct 2013 [cached]
John Kolman Executive Director, Head of Genomics BioReliance by SAFC, a member of Sigma-Aldrich Group During five years tenure with the company, Dr. Kolman built and leads the multiple laboratories that comprise BioReliance Genomics. Initially positioned to perform virus hunting as a unique application of massively parallel sequencing, the expertise of the laboratories has been expanded to support high-throughput custom clinical applications. John received his PhD from Yale University followed by Post-doc and Staff Scientist positions at the Salk Institute. Thereafter he served for three years as a member of the Corporate Research Laboratory of Invitrogen Corporation (Life Tech) before joining BioReliance.
Day One / World PGx by Hanson Wade, 1 May 2013 [cached]
John L. Kolman, Ph.D., Executive Director, Head of Genomics, BioReliance by SAFC, a member of Sigma-Aldrich Group
Other People with the name "Kolman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.